Humana Inc.

Filing receipts

“Interest Expense Interest expense increased $33 million, or 20.6%, from $160 million in the 2025 quarter to $193 million in the 2026 quarter primarily due to financing costs and higher average debt balances.”

“CenterWell Segment Change Three months ended March 31, Three months ended March 31, 2026 vs 2025 2026 2025 $ % ($ in millions) Revenues: Services: Home solutions $ 343 $ 335 $ 8 2.4% Pharmacy solutions 297 278 19 6.8% Primary care 788 469 319 68.0% Total external revenues 1,428 1,082 346 32.0% Intersegment revenues: Home solutions 683 497 186 37.4% Pharmacy solutions 2,855 2,566 289 11.3% Primary care 1,134 950 184 19.4% Intersegment revenues 4,672 4,013 659 16.4% Total revenues $ 6,100 $ 5,095 $ 1,005 19.7% Income from operations $ 289 $ 392 $ (103) (26.3)% Operating cost ratio 94.5% 91.1% 3.4% Income from operations CenterWell income from operations decreased $103 million, or 26.3%, from...”

“The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix.”